SCHEMBL30731869

SCHEMBL30731869

O=C1CCC(c2cccc(C(=O)N3CCN(CC4CCNCC4)CC3)c2)C(=O)N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 8/20 0.45
▸ CRBN Q96SW2 8/20 0.45
▸ CACNA2D1 P54289 1/20 0.44
▸ CACNA1B Q00975 1/20 0.44
▸ CACNB1 Q02641 1/20 0.44
▸ PARP1 P09874 1/20 0.42
▸ TPSAB1 Q15661 2/20 0.40
▸ TPSD1 Q9BZJ3 2/20 0.40
▸ TPSG1 Q9NRR2 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TNKS O95271 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30706112 0.99 DDB1 (0.44) DDB1CRBNCACNA2D1CACNA1BCACNB1
Hydrochloric Acid SCHEMBL26924650 0.99 DDB1 (0.44) DDB1CRBNCACNA2D1CACNA1BCACNB1
SCHEMBL31255522 0.88 DDB1 (0.46) DDB1CRBNTPSAB1TPSD1TPSG1
SCHEMBL31678103 0.87 DDB1 (0.53) DDB1CRBN
SCHEMBL30706056 0.84 CRBN (0.54) DDB1CRBNKDM4E
SCHEMBL26925223 0.84 CRBN (0.54) DDB1CRBNKDM4E
SCHEMBL31447868 0.83 DDB1 (0.51) DDB1CRBNCACNA2D1CACNA1BCACNB1
SCHEMBL31342193 0.82 CRBN (0.51) DDB1CRBNCACNA2D1CACNA1BCACNB1
SCHEMBL30732026 0.78 DDB1 (0.59) DDB1CRBNCACNA2D1CACNA1BCACNB1
SCHEMBL26925699 0.78 DDB1 (0.59) DDB1CRBNCACNA2D1CACNA1BCACNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2025-09-04 — — US disclosed
EP-4536650-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2025-04-16 — — EP disclosed
CN-119317623-A Tricyclic quinolone BCL6 bifunctional degradation agents 树线生物科学公司 2025-01-14 — — CN disclosed
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. 2024-08-29 — — US disclosed
WO-2023240038-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS Treeline Biosciences, Inc. (US) 2023-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287091-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR DDB1 92/4885CRBN 885/4885CACNA2D1 4695/4885
US-20250276981-A1 TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS BCL6, BCL6B, BCOR DDB1 92/4885CRBN 885/4885CACNA2D1 4695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback